Skip to main content

MINI REVIEW article

Front. Immunol.
Sec. B Cell Biology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1453833
This article is part of the Research Topic New Insights on B Cell Development in Poultry View all articles

Molecular Mechanisms of Avian Immunoglobulin Gene Diversification and Prospect for Industrial Applications

Provisionally accepted
Hidetaka Seo Hidetaka Seo 1*Kouji Hirota Kouji Hirota 2Kunihiro Ohta Kunihiro Ohta 1
  • 1 The University of Tokyo, Bunkyo, Japan
  • 2 Tokyo Metropolitan University, Hachioji, Tōkyō, Japan

The final, formatted version of the article will be published soon.

    Poultry immunoglobulin genes undergo diversification through homologous recombination (HR) and somatic hypermutation (SHM). Most animals share a similar system in immunoglobulin diversification, with the rare exception that human and murine immunoglobulin genes diversify through V(D)J recombination. Poultry possesses only one functional variable gene for each immunoglobulin heavy (HC) and light chains (LC), with clusters of non-productive pseudogenes upstream. During the B cell development, the functional variable gene is overwritten by sequences from the pseudo-variable genes via a process known as gene conversion (GC), a kind of HR. Point mutations caused in the functional variable gene also contribute to immunoglobulin diversification. This review discusses the latest findings on the molecular mechanisms of antibody gene diversification in poultry, using chickens as a model. Additionally, it will outline how these basic research findings have recently been applied especially in the medical field. Deleted: This enhancement suggests potential for increased diversification of the immunoglobulin genes and facilitates the construction of a Deleted: ntibody Deleted: . From these libraries Deleted: chicken IgM Deleted: Deleted: . Deleted: s Deleted: generate antigen-specific monoclonal antibodies Deleted: have been Deleted: Since the antibodies generated by DT40 are chicken IgMs, humanization is necessary to reduce immunogenicity.

    Keywords: gene conversion1, somatic hypermutation2, homologous recombination3, DNA damage tolerance4, monoclonal antibody5, therapeutic antibody6

    Received: 24 Jun 2024; Accepted: 26 Aug 2024.

    Copyright: © 2024 Seo, Hirota and Ohta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hidetaka Seo, The University of Tokyo, Bunkyo, Japan

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.